Br[C:2]1[C:3]([F:14])=[CH:4][N:5]=[C:6]2[C:11]=1[N:10]=[C:9]([O:12][CH3:13])[CH:8]=[CH:7]2.[O-]P([O-])([O-])=O.[K+].[K+].[K+].[CH2:23]([O:30][C:31](=[O:37])[NH:32][CH:33]1[CH2:36][NH:35][CH2:34]1)[C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.C1C=CC(P(C2C(OC3C(P(C4C=CC=CC=4)C4C=CC=CC=4)=CC=CC=3)=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:23]([O:30][C:31](=[O:37])[NH:32][CH:33]1[CH2:36][N:35]([C:2]2[C:11]3[C:6](=[CH:7][CH:8]=[C:9]([O:12][CH3:13])[N:10]=3)[N:5]=[CH:4][C:3]=2[F:14])[CH2:34]1)[C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1An oven-dried vial was charged with 8-bromo-7-fluoro-2-methoxy-[1,5]naphthyridine (commercial; 2.0 g, 7.78 mmol), palladium(II) acetate (70 mg, 0.31 mmol), DPEphos (335 mg, 0.62 mmol), K3PO4 (4.13 g, 19.45 mmol) and azetidin-3-yl-carbamic acid benzyl ester (1.68 g, 8.17 mmol). The resulting mixture was purged with argon for several min. Dioxane (25 mL) was then added via syringe and the resulting suspension was purged with argon for 3 min. The mixture was then heated at 85° C. overnight. The solvent was removed in vacuo and the residue was extracted with EA/water. The org. layer was washed with brine, dried over MgSO4 and concentrated. To the resulting solid TBME and a few drops of DCM and MeOH were added and the mixture was sonicated for 5 min and filtered to afford the title intermediate as a beige solid (2.53 g, 85%).
Loading…